substance use disorder epidemiology forecast

Key Highlights

• A Substance Use Disorder (SUD) is a medical condition that is defined by the inability to control the use of a particular substance (or substances) despite harmful consequences. SUDs may range from mild to severe, with severity depending on the number of diagnostic criteria a person meets.
• As per Delveinsight, the total number of diagnosed prevalent cases of Substance Use Disorder (SUD) in the US is ~66 million in 2023.
• In 2023, the tobacco use substance segment accounted for the highest number of cases in the US i.e., 26 million cases whereas, the cocaine use disorder segment had the least number of cases accounting for 1 million cases in US.
• Common therapeutic approaches include Cognitive Behavioural Therapy (CBT) to address negative thought patterns, Contingency Management (CM) to encourage sobriety with rewards, Motivational Interviewing (MI) to resolve ambivalence, and Dialectical Behavioural Therapy (DBT) to regulate emotions and reduce cravings.
• Currently available medications serve three main purposes: managing acute withdrawal during detoxification, reducing cravings and urges in initial recovery, and preventing relapse to compulsive drug use.

DelveInsight’s  “Substance Use Disorder (SUD) – Epidemiology Forecast – 2034” report delivers an in-depth understanding of Substance Use Disorder (SUD), historical and forecasted epidemiology in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.

The table given below further depicts the key segments provided in the report:

Substance Use Disorder (SUD): Disease Understanding 

Substance Use Disorder (SUD) Overview, and Diagnosis

SUD is the medical term used to describe a pattern of using a substance (drug) that causes significant problems or distress. This may be missing work or school or using the substance in dangerous situations, such as driving a car. It may lead to substance-related legal problems or continued substance use that interferes with friendships, family relationships, or both. SUD, as a recognized medical brain disorder, refers to the use of illegal substances, such as marijuana, heroin, cocaine, or methamphetamine. Or the misuse of legal substances, such as alcohol, nicotine, or prescription medicines. Alcohol is the most common legal drug associated with SUD.

The diagnostic process typically involves a comprehensive evaluation by a healthcare professional, such as a psychiatrist or licensed counsellor. It also involves a thorough history-taking that includes questions about the frequency and patterns of substance use and its impact on daily life and functioning. Physical examinations and laboratory tests may be conducted to assess overall health and identify any medical complications related to substance use. The diagnosis of SUD relies on specific criteria outlined in the DSM-5, which categorizes symptoms into four main areas: impaired control, social impairment, risky use, and pharmacological criteria.

Biomarkers also play a crucial role in diagnosing and understanding SUDs by offering valuable insights into the physiological and biochemical changes that occur with substance use, thereby enhancing both diagnostic accuracy and treatment strategies.

Substance Use Disorder (SUD) Epidemiology

The Substance Use Disorder (SUD) epidemiology chapter in the report provides historical as well as forecasted epidemiology segmented by The Total Diagnosed Prevalent Cases Of Substance Use Disorder (SUD), Substance Type Specific Cases Of Substance Use Disorder (SUD), and Total Treated Cases Of Substance Use Disorder (SUD) in the United States, EU4 countries (Germany, France, Italy, Spain) and the United Kingdom, and Japan from 2021 to 2034.

• In the 7MM, the total number of diagnosed prevalent cases of Substance Use Disorder were ~143 million in 2023.
• Highest cases of Substance Use Disorder (SUD) is related to Tobacco and this trend is expected to persist in the forecast period. Overall Tobacco Use Disorder (TUD) cases contributed to approximately 40% of the total diagnosed prevalent cases in 2023 in the US.
• In 2023, the prevalent cases of cannabis use disorder and alcohol use disorder in the United States were 16 million and 20 million.
• Germany has the most prevalent cases of Substance Use Disorder among EU4 and UK, whereas the UK has the fewest.
• The projected diagnosed prevalence growth rate of Substance Use Disorder (SUD) is nearly 0.3%.

Scope of the Report

• The report covers a segment of key events, an executive summary, and a descriptive overview of Substance Use Disorder (SUD), explaining its causes, signs and symptoms, pathogenesis, and currently available therapies.
• Comprehensive insight into the epidemiology segments and forecasts, the future growth potential of diagnosis rate, and disease progression have been provided.
• A detailed review of current challenges in establishing diagnosis and diagnosis rate is provided.

Substance Use Disorder (SUD) Report Insights

• Patient Population
• Country-wise Epidemiology Distribution

Substance Use Disorder (SUD) Report Key Strengths

• Eleven-year Forecast
• The 7MM Coverage 
• Substance Use Disorder (SUD) Epidemiology Segmentation

Substance Use Disorder (SUD) Report Assessment

• Epidemiology Segmentation
• Current Diagnostic Practices

FAQs

Epidemiology Insights

• What are the disease risks, burdens, and unmet needs of Substance Use Disorder (SUD)? What will be the growth opportunities across the 7MM with respect to the patient population pertaining to Substance Use Disorder (SUD)?
• What is the historical and forecasted Substance Use Disorder (SUD) patient pool in the United States, EU4 (Germany, France, Italy, Spain) and the United Kingdom, and Japan?
• What is the diagnostic pattern of Substance Use Disorder (SUD)?
• Which clinical factors will affect Substance Use Disorder (SUD)?
• Which factors will affect the increase in the diagnosis of Substance Use Disorder (SUD)?
• Which substance type has a high patient share in the SUD?

Reasons to buy

• Insights on disease burden, details regarding diagnosis, and factors contributing to the change in the epidemiology of the disease during the forecast years.
• To understand the change in Substance Use Disorder (SUD) cases in varying geographies over the coming years.
• A detailed overview of total diagnosed prevalent cases of Substance Use Disorder (SUD), substance type specific cases of Substance Use Disorder (SUD), and total treated cases of Substance Use Disorder (SUD) is included.
• To understand the perspective of key opinion leaders around the current challenges with establishing the diagnosis and insights on the treatment-eligible patient pool.
• Detailed insights on various factors hampering disease diagnosis and other existing diagnostic challenges.